Health ❯ Pharmaceuticals ❯ Drug Safety

Regulatory Affairs

FDA FDA Guidelines Quality Control FDA Approval

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

A confirmatory trial submitted this year showed excess thrombotic events versus usual care.

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections